AVE
AVECHO BIOTECHNOLOGY LIMITED
$0.0190
▼ -5.00%
Market cap
$73M
Turnover
$169,871
Last price
$0.0190
Day change
-5.00%
Announcements
12
Range, past year
Open 0.006 · Low 0.003 · Now 0.019 · High 0.027
Open AVE in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
AVE momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
27/100
Wyckoff phase
Accumulation17d
Trend stage
Distribution
1 Day
-5.0%
1 Week
+0.0%
1 Month
-17.4%
1 Year
+216.7%
RSI
45
Avg daily range
9.5%
AVECHO BIOTECHNOLOGY LIMITED scores 27 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Distribution.
On the Wyckoff cycle it sits in Accumulation, where it has been for 17 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -24.0%
- High volatility (ATR 9.5%)
- Risk rating: High
- Composite downside risk elevated
AVE announcements
Recent price-sensitive releases.
- 2026-08-31 Avecho enters final stage of Phase III insomnia trial Progress Report
- 2026-08-26 Appendix 4D and Half-year Financial Report Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
- 2026-07-29 June 2026 Quarterly Activities Report & Appendix 4C Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
- 2026-06-24 Positive interim results from Phase III insomnia program
- 2026-06-22 Trading Halt
- 2026-05-22 Receipt of Research & Development Tax Incentive
- 2026-05-21 Avecho completes treatment for Phase III interim analysis
More Health Care stocks
Most traded in the same sector.